Article info

Download PDFPDF

Antidepressant medication and ocular factors in association with the need for anti-VEGF retreatment in neovascular age-related macular degeneration

Authors

  • Irmela Mantel Department of Ophthalmology, University of Lausanne, Jules Gonin Eye Hospital, Fondation Asile des Aveugles, Lausanne, Switzerland PubMed articlesGoogle scholar articles
  • Marta Zola Department of Ophthalmology, University of Lausanne, Jules Gonin Eye Hospital, Fondation Asile des Aveugles, Lausanne, Switzerland PubMed articlesGoogle scholar articles
  • Olivier Mir Department of Ambulatory Care, University Paris Saclay, Villejuif, France PubMed articlesGoogle scholar articles
  • Raphael Gaillard Service de Psychiatrie, Centre Hospitalier Sainte-Anne, Université Paris Descartes, Sorbonne Paris Cité, Faculté de Médecine Paris Descartes, Paris, France Human Histopathology and Animal Models, Infection and Epidemiology Department, Institut Pasteur, Paris, France PubMed articlesGoogle scholar articles
  • Francine Behar-Cohen Department of Ophthalmology, University of Lausanne, Lausanne, Switzerland Inserm U1138, Team 17, From Physiopathology of Ocular Diseases to Clinical Development, Université Paris Descartes Sorbonne Paris Cité, Centre de Recherche des Cordeliers, Paris, France PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Irmela Mantel, Jules Gonin Eye Hospital, Lausanne 1002, Switzerland; irmela.mantel{at}fa2.ch
View Full Text

Citation

Mantel I, Zola M, Mir O, et al
Antidepressant medication and ocular factors in association with the need for anti-VEGF retreatment in neovascular age-related macular degeneration

Publication history

  • Received March 25, 2018
  • Revised May 28, 2018
  • Accepted July 2, 2018
  • First published July 20, 2018.
Online issue publication 
May 28, 2019

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.